Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Because ziprasidone has not been extensively studied and is not widely accepted in the
severely mentally ill in State hospitals this study aims to demonstrate its effectiveness and
relative lack of side effects. 75 patients with schizophrenia or schizoaffective disorder who
need a change of medication because of ineffectiveness or side effects will be changed to
ziprasidone and followed with detailed assessments for eight weeks.
The hypothesis is that they will improve and have fewer side effects.
Phase:
Phase 4
Details
Lead Sponsor:
Bronx Psychiatric Center
Collaborators:
Buffalo Psychiatric Center Pfizer Rochester Psychiatric Center